Ann Dermatol.
2011 Oct;23(Suppl 2):S182-S184. 10.5021/ad.2011.23.S2.S182.
Epidermal Cysts in a Tacrolimus Treated Renal Transplant Recipient
- Affiliations
-
- 1Department of Dermatology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea. dermap@paran.com
- KMID: 2156784
- DOI: http://doi.org/10.5021/ad.2011.23.S2.S182
Abstract
- Tacrolimus, a calcineurin inhibitor, formerly also known as FK506, is a macrolactam drug isolated from Streptomyces tsukubaensis. Its mode of action closely parallels the action of cyclosprorin A (CsA) and can be used for the treatment of inflammatory and autoimmune skin diseases in which systemic CsA has proved effective against psoriasis, pyoderma gangrenosum, atopic dermatitis, lupus erythematosus and graft versus host disease (GVHD). Although several cases of epidermal cysts have been reported in patients using cyclosporine and other immunosuppressants after organ transplantation; such types of cases have yet not been reported after administration of tacrolimus. However, we report herein a case of presence of multiple, various sized epidermal cysts in a renal transplant recipient receiving tacrolimus.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Cryptococcosis with Skin Involvement in a Liver Transplant Recipient
- Risk of graft loss on once-daily versus twice-daily tacrolimus in kidney transplant patients: a meta-analysis
- The comparison of coefficient of variation among once-daily and twice-daily tacrolimus in kidney transplant patients: a meta-analysis
- Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinoma
- Intrarenal Epidermal Cyst
